SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Galapagos Islands -- Ignore unavailable to you. Want to Upgrade?


To: X Y Zebra who wrote (10439)10/30/2002 9:30:28 AM
From: MulhollandDrive  Read Replies (1) | Respond to of 57110
 
great news for teva...rock it should.

Commenting on today's approval, Israel Makov, President and CEO of Teva Pharmaceuticals said "We are delighted to receive final approval of our generic version of Augmentin(R) and look forward to helping American consumers get affordable access to this important drug. We expect that this will quickly become one of Teva's most important products